DURHAM, N.C., June 17, 2014 (GLOBE NEWSWIRE) -- Chimerix, Inc. (Nasdaq:CMRX), a biopharmaceutical company developing novel, oral antivirals in areas of high unmet medical need, today announced that M. Michelle Berrey, M.D., M.P.H., President, CEO, and Chief Medical Officer of Chimerix, will present at the JMP Securities Health Care Conference 2014 on Tuesday, June 24, 2014 at 4:30pm EST at The Westin New York Grand Central in New York.
Help employers find you! Check out all the jobs and post your resume.
